772 related articles for article (PubMed ID: 18001177)
1. Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis.
Kubota S; Amino N; Matsumoto Y; Ikeda N; Morita S; Kudo T; Ohye H; Nishihara E; Ito M; Fukata S; Miyauchi A
Thyroid; 2008 Mar; 18(3):283-7. PubMed ID: 18001177
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
Izumi Y; Takeoka K; Amino N
Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
[TBL] [Abstract][Full Text] [Related]
3. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease.
Ota H; Amino N; Morita S; Kobayashi K; Kubota S; Fukata S; Kamiyama N; Miyauchi A
Clin Endocrinol (Oxf); 2007 Jul; 67(1):41-5. PubMed ID: 17437515
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of transient thyrotoxicosis after antithyroid drug therapy in patients with Graves' disease.
Kubota S; Takata K; Arishima T; Ohye H; Nishihara E; Kudo T; Ito M; Fukata S; Amino N; Miyauchi A
Thyroid; 2008 Jan; 18(1):63-6. PubMed ID: 18302519
[TBL] [Abstract][Full Text] [Related]
5. Abnormal Liver Blood Tests in Patients with Hyperthyroidism: Systematic Review and Meta-Analysis.
Scappaticcio L; Longo M; Maiorino MI; Pernice V; Caruso P; Esposito K; Bellastella G
Thyroid; 2021 Jun; 31(6):884-894. PubMed ID: 33327837
[No Abstract] [Full Text] [Related]
6. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
7. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
Yoshimura Noh J; Momotani N; Fukada S; Ito K; Miyauchi A; Amino N
Endocr J; 2005 Oct; 52(5):537-42. PubMed ID: 16284430
[TBL] [Abstract][Full Text] [Related]
8. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
Izumi Y; Hidaka Y; Tada H; Takano T; Kashiwai T; Tatsumi KI; Ichihara K; Amino N
Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
[TBL] [Abstract][Full Text] [Related]
9. Transient hyperthyroidism after withdrawal of antithyroid drugs in patients with Graves' disease.
Kubota S; Tamai H; Ohye H; Fukata S; Kuma K; Miyauchi A
Endocr J; 2004 Apr; 51(2):213-7. PubMed ID: 15118273
[TBL] [Abstract][Full Text] [Related]
10. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
[TBL] [Abstract][Full Text] [Related]
11. Cutoff value of thyroid uptake of (99m)Tc-pertechnetate to discriminate between Graves' disease and painless thyroiditis: a single center retrospective study.
Uchida T; Suzuki R; Kasai T; Onose H; Komiya K; Goto H; Takeno K; Ishii S; Sato J; Honda A; Kawano Y; Himuro M; Yamada E; Yamada T; Watada H
Endocr J; 2016; 63(2):143-9. PubMed ID: 26581846
[TBL] [Abstract][Full Text] [Related]
12. [Thyrotoxicosis hepatitis: a case report].
Bellassoued M; Mnif M; Kaffel N; Rekik N; Rebai T; Tahri N; Krichen MS; Abid M
Ann Endocrinol (Paris); 2001 Jun; 62(3):235-8. PubMed ID: 11458176
[TBL] [Abstract][Full Text] [Related]
13. Painless thyroiditis mimicking relapse of hyperthyroidism during or after potassium iodide or thionamide therapy for Graves' disease resulting in remission.
Okamura K; Sato K; Fujikawa M; Bandai S; Ikenoue H; Kitazono T
Endocr J; 2023 Feb; 70(2):207-222. PubMed ID: 36351595
[TBL] [Abstract][Full Text] [Related]
14. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.
Huang MJ; Li KL; Wei JS; Wu SS; Fan KD; Liaw YF
Am J Gastroenterol; 1994 Jul; 89(7):1071-6. PubMed ID: 7912472
[TBL] [Abstract][Full Text] [Related]
15. Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.
Žarković M; Wiersinga W; Perros P; Bartalena L; Donati S; Okosieme O; Morris D; Fichter N; Lareida J; Daumerie C; Burlacu MC; Kahaly GJ; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
J Endocrinol Invest; 2021 Feb; 44(2):371-378. PubMed ID: 32524368
[TBL] [Abstract][Full Text] [Related]
16. Hypocalcaemia following therapy of thyrotoxicosis in an infant.
Kansra S; Devidayal ; Suri D; Singh M
Acta Paediatr; 2006 Mar; 95(3):375-7. PubMed ID: 16497652
[TBL] [Abstract][Full Text] [Related]
17. Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis.
Nagasaka S; Sugimoto H; Nakamura T; Kusaka I; Fujisawa G; Sakuma N; Tsuboi Y; Fukuda S; Honda K; Okada K; Ishikawa S; Saito T
Clin Endocrinol (Oxf); 1997 Aug; 47(2):215-21. PubMed ID: 9302397
[TBL] [Abstract][Full Text] [Related]
18. Clinical Studies on Potassium Iodide-induced Painless Thyroiditis in 11 Graves' Disease Patients.
Kamijo K
Intern Med; 2021 Jun; 60(11):1675-1680. PubMed ID: 33431733
[TBL] [Abstract][Full Text] [Related]
19. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
Chen DY; Chen TH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
